Cell Pathways - Ownership and Business Overview

Life ScienceCompany

Cell Pathways Ownership

Who owns Cell Pathways?

Cell Pathways is owned by OSI Pharmaceuticals. It was acquired on February 11, 2003.

Was Cell Pathways formerly PE-backed?

Yes. Cell Pathways was formerly owned by 1 private investor.

Cell Pathways Business Overview

Where is Cell Pathways headquartered?

Cell Pathways is headquartered in Horsham, Pennsylvania.

How many employees does Cell Pathways have?

Cell Pathways has 34 employees.

What sector is Cell Pathways in?

Cell Pathways is a life science company.

When was Cell Pathways founded?

Cell Pathways was founded in 1990.

Life Science M&A Summary in 2003

Out of 60 sectors in the Mergr database, life science ranked 12 in number of deals in 2003. The largest life science acquisition in 2003 was Pharmacia - which was acquired by Pfizer for $60.0B.

Join Mergr to view all 42 acquisitions of life science companies in 2003, including 14 acquisitions by private equity firms, and 28 by strategics.

Cell Pathways, Inc.

702 Electronic Drive,
Horsham, Pennsylvania 19044
United States,
(215) 706-3800

Cell Pathways, Inc develops and commercializes drugs for the prevention and treatment of cancer.

 Subscribe to unlock this and 202,409
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.